ICCA Global CancerCare

Global cancer center offering next-generation therapies like bispecific vaccine; intratumoral immunotherapy and more, unavailable in the U.S. and Canada.

[ICCA Global CancerCare @Iccacancercare]

@exosome Without a doubt. ICCA CancerCare leads the charge in bringing next-gen immunotherapy to late stage cancer patients via intratumorally injected vaccines and solid tumor antibodies, light years away from getting approved in U.S. NK and T cells are the Holy Grail.

[ICCA Global CancerCare @Iccacancercare]

@liuxuewu Congratulations Liu. You are well intended and your persistence is what it will take to get your protocol ultimately accepted by mainstream medicine!

[ICCA Global CancerCare @Iccacancercare]

Novel Vaccine - Solid Tumors

[ICCA Global CancerCare @Iccacancercare]

@jasonwilliamsmd Access to the tumor is often challenging.

[ICCA Global CancerCare @Iccacancercare]

@jasonwilliamsmd We were introduced to intratumoral chemotherapy in 2015 from our oncologic colleagues in China. We have since moved into intratumoral immunotherapy with PD1 or PDL1 adjuvants. This far surpasses systemic chemotherapy in our clinical experience.

[ICCA Global CancerCare @Iccacancercare]

@OpulentDreamer @FDA @CDCgov @SecKennedy @POTUS @DrOzCMS There are viable options to both your son and your husband. They are just not promoted aggrssively.

[ICCA Global CancerCare @Iccacancercare]

@exosome Hey, count us in!

[ICCA Global CancerCare @Iccacancercare]

Why Wait! Do It Now!

[ICCA Global CancerCare @Iccacancercare]

Breast Cancer Warrior!

[ICCA Global CancerCare @Iccacancercare]

@exosome @DendreonNews We make fresh dendritic cells. And for you, pro Bono!

[ICCA Global CancerCare @Iccacancercare]

@BenSasse considered looking beyond U.S. for outstanding next gen cancer care, that actually have new treatment modalities 10 years away from approval in the U.S. to wit, bispecific EpCAM/CD3 vaccine like antibody developed for adenocarcinomas; https://t.co/9tKj2X4BuQ. Nothing to lose!

[ICCA Global CancerCare @Iccacancercare]

@BenSasse There is legitimate, excellent, next generation cancer care outside the U.S. At least take a moment to explore! https://t.co/9tKj2X4BuQ

[ICCA Global CancerCare @Iccacancercare]

@DrPatrick Fresh allogenic NK cells can help!

[ICCA Global CancerCare @Iccacancercare]

#NewProfilePic

[ICCA Global CancerCare @Iccacancercare]

@jasonwilliamsmd Thanks again Dr Williams! Your intuitive and clinical insights are always timely and relevant. Our center is currently using a less ubiquitous il12 because we primarily focus on highly expressive EpCAM surfaces (e.g, adenos) wherein Anktiva is applied to the masses so to speak.

[ICCA Global CancerCare @Iccacancercare]

@GreereMedeea We don’t challenge Dr Soon-Shidong’s contributions to cancer therapy nor brilliance however, in years of clinical use, we’ve found that hypofractionated radiation with chemosensitizing agent (say 10 fractions 3Gy/fraction) can be beneficial without compromising immune system.

[ICCA Global CancerCare @Iccacancercare]

ICCA Solid Tumor Vaccine

[ICCA Global CancerCare @Iccacancercare]

Why We Exist!!

[ICCA Global CancerCare @Iccacancercare]

You Should Ask!

[ICCA Global CancerCare @Iccacancercare]

We have it!